Antitumor activity of saracatinib, a c-Src/Abl kinase inhibitor, in gastric cancer

被引：0
|
作者：
Nam, Hyun-Jin [1 ]
Oh, Do-Youn [1 ]
Im, Seock-Ah [1 ]
Kim, Hwang-Phill [1 ]
Yoon, Young-Kwang [1 ]
Min, Ah-Rum [1 ]
Song, Sang-Hyun [1 ]
Han, Sae-Won [1 ]
Kim, Tae-You [1 ]
Bang, Yung-Jue [1 ]
机构：
[1] Seoul Natl Univ, Seoul, South Korea
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-3588
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3588
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Antitumor Activity of Saracatinib (AZD0530), a c-Src/Abl Kinase Inhibitor, Alone or in Combination with Chemotherapeutic Agents in Gastric Cancer
    Nam, Hyun-Jin
    Im, Seock-Ah
    Oh, Do-Youn
    Elvin, Paul
    Kim, Hwang-Phill
    Yoon, Young-Kwang
    Min, Ahrum
    Song, Sang-Hyun
    Han, Sae-Won
    Kim, Tae-You
    Bang, Yung-Jue
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (01) : 16 - 26
  • [2] Saracatinib. Dual Src/ABL kinase inhibitor, Oncolytic.
    Dulsat, C.
    Mealy, N.
    Castaner, R.
    DRUGS OF THE FUTURE, 2009, 34 (02) : 106 - 114
  • [3] Disrupted target binding with acryloyl group as potential Bcr-Abl/C-Src dual kinase inhibitor optimization strategies with maintained antitumor activity
    Lin, Ching
    Chiang, Hsin-Yi
    Chen, Grace Shiahuy
    Chern, Ji-Wang
    Yu, Chao-Wu
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2025, 119
  • [4] 3D-QSAR studies on c-Src kinase inhibitors and docking analyses of a potent dual kinase inhibitor of c-Src and c-Abl kinases
    Thaimattam, R
    Daga, PR
    Banerjee, R
    Iqbal, J
    BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (15) : 4704 - 4712
  • [5] Antiproliferative activity of c-src kinase inhibitor saracatinib correlates with expression of insulin-like and epidermal growth factor receptors in ovarian cancer cell lines
    Spillman, M.
    Helfrich, B.
    Conner, A.
    Conageski, C.
    Behbakht, K.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S158 - S159
  • [6] Why is Gleevec a specific and potent inhibitor of Abl but not of c-Src?
    Meng, Yilin
    Lin, Yen-Lin
    Jiang, Wei
    Roux, Benoit
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [7] Development of a Highly Selective c-Src Kinase Inhibitor
    Brandvold, Kristoffer R.
    Steffey, Michael E.
    Fox, Christel C.
    Soellner, Matthew B.
    ACS CHEMICAL BIOLOGY, 2012, 7 (08) : 1393 - 1398
  • [8] Development of a Chimeric c-Src Kinase and HDAC Inhibitor
    Ko, Kristin S.
    Steffey, Michael E.
    Brandvold, Kristoffer R.
    Soellner, Matthew B.
    ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (08): : 779 - 783
  • [9] Role of c-Src activity in the regulation of gastric cancer cell migration
    Yang, Yun
    Bai, Zhi-Gang
    Yin, Jie
    Wu, Guo-Cong
    Zhang, Zhong-Tao
    ONCOLOGY REPORTS, 2014, 32 (01) : 45 - 49
  • [10] Mechanisms of acquired resistance to c-Src kinase inhibitor in triple negative breast cancer
    Gilani, Rabia A.
    Lachacz, Eric J.
    Phadke, Sameer
    Bao, Li Wei
    Cheng, Xu
    Jiagge, Evelyn M.
    Soellner, Matthew B.
    Merajver, Sofia D.
    CANCER RESEARCH, 2017, 77
12345